Sequential imaging approach with lymphoscintigraphy and intraoperative indocyanine green lymphography for refractory chylous ascites in an infant: A case report Authors: Taku Yamamichi, Ryo Tsukada, Shun Iwasaki, Ryuta Saka Published: 2026 ABSTRACT A 4-month-old female presented with progressive abdominal distention and feeding difficulties. Diagnostic laparoscopy with peritoneal drainage yielded 970 mL of milky ascites. Fluid analysis confirmed chylous ascites (triglyceride level, 3177 mg/dL; lymphocyte predominance, 94.8%) with negative culture and cytology results. Contrast-enhanced abdominal computed tomography revealed massive ascites without intra-abdominal lesions or significant lymphadenopathy. Despite conservative therapy and continuous high-output drainage (approximately 500 mL/day), the leak persisted. Planar lymphoscintigraphy with technetium-99m radiotracer injected subcutaneously into the dorsum of both feet confirmed lymphatic leakage into the ascites and provided regional guidance regarding the suspected source; however, no discrete focal hotspots were identified. Based on these scintigraphic findings, intraoperative near-infrared fluorescence lymphography using indocyanine green was performed the following day, enabling real-time visualization of active leakage and facilitating targeted laparoscopic treatment. Targeted electrocautery ablation markedly reduced leakage on real-time fluorescence imaging, and a fibrin sealant was subsequently applied. The patient ultimately achieved full oral feeding and showed no recurrence of ascites at the 2-year follow-up. This case illustrates a practical sequential imaging approach for refractory pediatric chylous ascites: lymphoscintigraphy for functional confirmation and regional guidance, followed by intraoperative indocyanine green fluorescence for focal confirmation and targeted treatment. Introduction Chylous ascites is an uncommon cause of ascites in infants and children, most often reflecting congenital lymphatic dysplasia or malformation; though acquired etiologies are also recognized. Persistent chyle loss may cause nutritional depletion and immunological compromise, making prompt diagnosis and effective control of leakage clinically important. Conservative therapy—dietary fat modification with medium-chain triglycerides, bowel rest or total parenteral nutrition, and adjunct pharmacological therapy—remains the first-line treatment; however, some patients develop refractory, high-output leakage requiring definitive intervention [1]. Accurate localization of the responsible lymphatic disruption is a major barrier to targeted treatment. Conventional cross-sectional imaging is essential for evaluating secondary causes but frequently fails to identify a focal leak. Recent advances in pediatric lymphatic imaging, including lymphoscintigraphy, dynamic contrast-enhanced magnetic resonance (MR) lymphangiography, computed tomography (CT) lymphangiography, and intranodal lymphangiography with potential embolization, have expanded the diagnostic and therapeutic armamentarium; however, access to these modalities and actionable localization may remain challenging in small infants [[2], [3], [4], [5], [6]]. Near-infrared fluorescence lymphography using indocyanine green (ICG) has emerged as a practical adjunct for real-time lymphatic mapping in pediatric surgery and has been described in neonatal and infant lymphatic disorders, including chylous ascites [[7], [8], [9], [10], [11]]. We report a case of refractory chylous ascites in which planar lymphoscintigraphy confirmed lymphatic leakage into the ascitic fluid and provided clinically useful regional guidance, although focal localization remained limited. Using the same pedal route, intraoperative ICG fluorescence lymphography enabled real-time confirmation of active leakage and guided targeted laparoscopic management, resulting in durable clinical resolution during follow-up. Case report A 4-month-old female with congenital hypothyroidism presented with progressive abdominal distension and feeding difficulty during outpatient follow-up. Her parents reported mild abdominal distension and slow feeding from approximately 1 month of age, with gradual worsening over the following 3 months. She was born at 39 weeks and 4 days of gestation via cesarean section (birth weight, 3216 g; Apgar scores, 8 and 9). On admission, her body temperature was 37.5°C, heart rate was 150 beats/min, respiratory rate was 55 breaths/min, and oxygen saturation was 100% on room air. She appeared pale and uncomfortable in the supine position. Physical examination revealed marked abdominal distension with a tense abdomen but no definite peritoneal signs. No palpable hepatomegaly or abdominal masses were observed. An umbilical hernia was observed. Her length was 60.5 cm (−1.0 SD), and her body weight was 6005 g (−0.7 SD), including a substantial volume of ascites. Thyroid function was reported to be well controlled. Laboratory testing showed a white blood cell count of 9600/μL, C-reactive protein level of 2.69 mg/dL, serum albumin level of 3.4 g/dL, and serum sodium level of 129 mEq/L. Plain radiographs of the chest and abdomen revealed displacement of the small bowel loops and diaphragm elevation, consistent with massive ascites (Fig. 1A). Abdominal ultrasonography revealed a large volume of ascites without biliary dilatation or an obvious causative lesion. Preoperative contrast-enhanced abdominal and pelvic CT revealed massive ascites without an obvious intra-abdominal lesion, gastrointestinal abnormality, or significant lymphadenopathy (Fig. 2).Fig. 1Admission and discharge radiographs. Frontal radiographs of the chest and abdomen of a 4-month-old female with chylous ascites. (A) Admission radiograph demonstrating marked abdominal distension with bowel loop displacement and diaphragm elevation, consistent with massive ascites. (B) Radiograph at discharge showing improvement in abdominal distension after definitive management.Fig 1 – dummy alt textFig. 2Contrast-enhanced computed tomography (CT) confirming massive ascites without secondary causes. Contrast-enhanced CT of the abdomen and pelvis. (A) Axial image showing massive ascites with centrally displaced bowel loops. (B) Coronal image showing diffuse peritoneal fluid without an obvious intra-abdominal mass lesion or significant lymphadenopathy.Fig 2 – dummy alt text Admission and discharge radiographs. Frontal radiographs of the chest and abdomen of a 4-month-old female with chylous ascites. (A) Admission radiograph demonstrating marked abdominal distension with bowel loop displacement and diaphragm elevation, consistent with massive ascites. (B) Radiograph at discharge showing improvement in abdominal distension after definitive management. Contrast-enhanced computed tomography (CT) confirming massive ascites without secondary causes. Contrast-enhanced CT of the abdomen and pelvis. (A) Axial image showing massive ascites with centrally displaced bowel loops. (B) Coronal image showing diffuse peritoneal fluid without an obvious intra-abdominal mass lesion or significant lymphadenopathy. After the initial laboratory evaluation and imaging on admission, diagnostic laparoscopy with placement of a peritoneal drainage catheter into the pouch of Douglas was performed on hospital day 2, the day after admission. During the procedure, 970 mL of milky ascitic fluid was aspirated and analyzed. Ascitic fluid analysis revealed triglyceride of 3177 mg/dL, total protein of 3.3 g/dL, albumin of 1.6 g/dL, and a cell count of 4030/μL with lymphocyte predominance (94.8%), confirming chylous ascites. The bacterial cultures and cytological tests were negative. With no secondary causes on CT, idiopathic chylous ascites was suspected. After laparoscopic drainage, management included conservative therapy (fasting and dietary modification, including medium-chain triglyceride–based feeding when feasible) and empiric adjunct therapies without clinical improvement, including Eppikajutsuto (0.4 g/kg/day), Goreisan (0.2 g/kg/day), sirolimus (0.5 mg every other day), and factor XIII concentrate (Fibrogammin®; 4 mL/day). Despite these measures, continuous high-output drainage persisted at approximately 500 mL/day, indicating the presence of refractory chylous ascites. To evaluate lymphatic leakage, planar lymphoscintigraphy was performed on hospital day 19 using a technetium-99m radiotracer (TECHNESCINTI® Injection-10M; Nihon Medi-Physics Co., Ltd., Tokyo, Japan) injected subcutaneously into the dorsum of both feet (activity: 74 MBq). Planar imaging without single-photon emission computed tomography/CT was performed at 5, 10, 20, 45, and 60 min. SPECT/CT was not performed to minimize incremental radiation (ALARA), as contrast-enhanced CT had already been obtained. This study demonstrated tracer uptake from the femoral lymphatic vessels to the inguinal lymph nodes and early tracer accumulation within the peritoneal fluid at approximately 20 min, supporting lymphatic leakage into the ascites. However, no discrete focal hot spot was identified to localize the precise disruption site in the images for up to 60 min (Fig. 3). Although focal localization remained limited, the demonstrated pedal lymphatic transit and early tracer accumulation within the ascites increased confidence that subsequent pedal near-infrared fluorescence lymphography could enable intraoperative confirmation and help anticipate the timing of fluorescence appearance.Fig. 3Lymphoscintigraphy suggesting peritoneal leakage (up to 60 min). Planar lymphoscintigraphy was performed to evaluate lymphatic leakage. Images were acquired at multiple time points up to 60 min after subcutaneous injection of a technetium-99m radiotracer (TECHNESCINTI® Injection-10M) into the dorsum of the feet (activity: 74 MBq). (A) At 20 min, abnormal radiotracer accumulation within the peritoneal fluid is observed (arrowheads), suggesting lymphatic leakage into the ascites. (B) At 60 min, progressive tracer accumulation within the peritoneal cavity persisted without a discrete focal hotspot to localize the precise disruption site.Fig 3 – dummy alt text Lymphoscintigraphy suggesting peritoneal leakage (up to 60 min). Planar lymphoscintigraphy was performed to evaluate lymphatic leakage. Images were acquired at multiple time points up to 60 min after subcutaneous injection of a technetium-99m radiotracer (TECHNESCINTI® Injection-10M) into the dorsum of the feet (activity: 74 MBq). (A) At 20 min, abnormal radiotracer accumulation within the peritoneal fluid is observed (arrowheads), suggesting lymphatic leakage into the ascites. (B) At 60 min, progressive tracer accumulation within the peritoneal cavity persisted without a discrete focal hotspot to localize the precise disruption site. Given persistent high-output chylous ascites and scintigraphic confirmation of lymphatic leakage with regional guidance but without actionable focal localization, laparoscopic exploration with intraoperative lymphatic mapping was performed on hospital day 20. Under general anesthesia in the supine Trendelenburg position, a 6.5-Fr enteral tube was placed fluoroscopically into the horizontal (third) portion of the duodenum, and melted high-fat ice cream (milk fat 15.0%, egg fat 0.8%) was administered (15 mL, with an additional 20 mL given intraoperatively). This high-fat challenge augmented chyle flow and facilitated leak detection in the presence of a mesenteric source. ICG (Diagnogreen® for Injection 25 mg; Daiichi Sankyo Co., Ltd., Tokyo, Japan) was reconstituted to 2.5 mg/mL and injected subcutaneously into the dorsum of both feet (0.05 mL per foot; total 0.1 mL, 0.25 mg, approximately 0.042 mg/kg). Near-infrared fluorescence imaging was performed using a 5-mm camera system (SPY-PHI; Stryker, Kalamazoo, MI, USA). Intraoperatively, fluorescence was first observed in the inguinal lymph nodes approximately 15 min after injection. After approximately 30 min, the ascitic fluid around the right paracolic gutter fluoresced. Approximately 40 min after the injection, active lymphatic leakage was visualized as fluorescent lymphatic fluid oozing from the retroperitoneum lateral to the right kidney into the peritoneal cavity (Fig. 4A; Video 1). Owing to the challenging ligation location, targeted electrocautery ablation was repeated, resulting in a marked reduction in leakage on real-time fluorescence imaging (Fig. 4B; Video 1). Fibrin sealant (Beriplast®; CSL Behring GmbH, Marburg, Germany) was then applied over the suspected leakage area. A total of 779 mL of ascitic fluid was aspirated intraoperatively. No drain remained in situ. The off-label use of ICG was approved by the institutional ethics review committee, and written informed consent was obtained from the patient’s guardian.Fig. 4Intraoperative near-infrared fluorescence lymphography using indocyanine green (ICG). ICG (2.5 mg/mL) was injected subcutaneously into the dorsum of both feet (0.05 mL per foot; total 0.1 mL, 0.25 mg; approximately 0.042 mg/kg), and fluorescence imaging was performed using a 5-mm camera system (Stryker SPY-PHI). (A) Active fluorescent lymphatic leakage (arrow) was visualized oozing from the retroperitoneum lateral to the right kidney into the peritoneal cavity (approximately 40 min after injection). (B) After repeated electrocautery ablation, fluorescent leakage was markedly decreased compared to that in panel A; the arrow indicates the prior leakage site.Fig 4 – dummy alt text Intraoperative near-infrared fluorescence lymphography using indocyanine green (ICG). ICG (2.5 mg/mL) was injected subcutaneously into the dorsum of both feet (0.05 mL per foot; total 0.1 mL, 0.25 mg; approximately 0.042 mg/kg), and fluorescence imaging was performed using a 5-mm camera system (Stryker SPY-PHI). (A) Active fluorescent lymphatic leakage (arrow) was visualized oozing from the retroperitoneum lateral to the right kidney into the peritoneal cavity (approximately 40 min after injection). (B) After repeated electrocautery ablation, fluorescent leakage was markedly decreased compared to that in panel A; the arrow indicates the prior leakage site. Medium-chain triglyceride (MCT)-based feeding was resumed on postoperative day 6. Adhesive ileus developed on postoperative day 13 and was treated using laparoscopic adhesiolysis. MCT feeding was restarted via tube feeding on postoperative day 17, followed by a gradual transition to regular milk. The patient achieved full oral feeding on postoperative day 25 and was discharged in good condition on postoperative day 29 (Fig. 1B). At 2-year follow-up, she remained clinically well without recurrence of ascites and showed appropriate weight gain (approximately −1 SD at the most recent visit). Discussion Chylous ascites is a rare but potentially morbid condition in children, characterized by leakage of triglyceride-rich lymphatic fluid into the peritoneal cavity. Congenital lymphatic dysplasia or malformation is a common etiology in infants and young children, whereas acquired causes include trauma, infection, inflammation, malignancy, liver disease, and iatrogenic lymphatic injury. Prolonged chyle loss may lead to malnutrition, electrolyte imbalance, lymphopenia, and immunoglobulin depletion, highlighting the need for early diagnosis and effective leak control [1]. A key challenge in refractory chylous ascites is localizing the responsible leak to enable targeted interventions. Cross-sectional imaging (ultrasonography/CT) is valuable for confirming ascites and evaluating secondary causes (e.g., mass lesions, lymphadenopathy, and venous obstruction); however, it frequently cannot identify focal lymphatic disruption. As lymphatic imaging has evolved, multiple modalities have become available for functional and anatomical evaluations, including lymphoscintigraphy, CT lymphangiography, MR lymphangiography, and invasive lymphangiography (most commonly via intranodal access), each with distinct strengths and limitations [[2], [3], [4]]. Lymphoscintigraphy is often used as an initial functional test to confirm lymphatic leakage and assess regional drainage patterns in a relatively noninvasive manner. In our case, it supported active lymphatic leakage into the ascites, but actionable focal localization remained limited because of the inherent spatial resolution of planar imaging and restricted anatomic correlation [3]. SPECT/CT, which can improve anatomic correlation, was not performed in this infant to avoid additional radiation exposure. In large-volume ascites, tracer dispersion may obscure a focal hot spot; intraoperative ICG enables dynamic real-time localization. Advanced lymphatic imaging may be considered when localization remains uncertain. Dynamic contrast-enhanced MR lymphangiography can delineate the central lymphatic anatomy and flow and support procedural planning in complex lymphatic disorders, although successful implementation typically requires specialized expertise and workflow [2,4]. Contrast-enhanced CT lymphangiography may be an alternative when magnetic resonance imaging is limited, balancing rapid acquisition with radiation exposure and technique requirements [3,5]. If the culprit channel is identified, intranodal lymphangiography with lymphatic embolization provides a combined diagnostic and therapeutic pathway and has been reported in pediatric iatrogenic chylous ascites [3,6]. Advanced lymphatic imaging/interventions were not readily available at our institution and may be technically challenging in a 6-kg infant; therefore we proceeded with planar lymphoscintigraphy followed by intraoperative pedal ICG fluorescence lymphography for focal confirmation and treatment. Despite these options, some patients remain refractory and nonlocalized and require definitive control. In this context, intraoperative near-infrared fluorescence lymphography using ICG can serve as a practical final-step localization technique. By providing real-time functional mapping of superficial lymphatic flow, fluorescence lymphography may bridge the gap between nonlocalizing preoperative imaging and targeted treatment. Although performed in the operating room, it effectively extends functional lymphatic imaging to a real-time, procedure-directed setting. The literature supports the feasibility of ICG lymphography in congenital lymphatic diseases. A neonatal series evaluating congenital chylothorax and chylous ascites reported that ICG lymphography is a clinically useful method for assessing lymphatic abnormalities [7]. Additionally, a pediatric case report described the successful management of refractory chylous ascites in an infant using intraoperative ICG fluorescence lymphography with adjuncts such as fibrin sealant and polyglycolic acid felt [8]. The same localization principle has also been demonstrated in the laparoscopic management of refractory chylous ascites using ICG fluorescence navigation in other settings [9]. In the present case, subcutaneous ICG injection into the dorsum of both feet enabled stepwise visualization of lymphatic transit and revealed active focal leakage from the retroperitoneum lateral to the right kidney, which was not actionable on lymphoscintigraphy. A concurrent fat challenge was used to augment lymph flow. Targeted electrocautery ablation at the fluorescent source, followed by fibrin sealant application, resulted in a marked reduction in leakage on real-time fluorescence imaging and provided immediate intraoperative feedback that was difficult to convey with white-light inspection alone. The patient achieved durable clinical resolution without recurrence at long-term follow-up. However, ICG fluorescence imaging has several limitations. Tissue penetration is limited to a few millimeters. Therefore, deeply located central lymphatic channels or leakage points may not be directly visualized unless they reach the surface or leak into an accessible space. Pediatric evidence remains heterogeneous regarding dosing, timing, and indications, and consensus statements and systematic reviews emphasize standardization and detailed documentation to improve reproducibility [10,11]. Accordingly, reporting the injection site, concentration, total dose, timing of fluorescence appearance, imaging system, and intraoperative decision points is essential. Clinically, this case supports a pragmatic sequential approach: (1) confirm the diagnosis biochemically, (2) evaluate secondary causes with cross-sectional imaging, (3) use lymphoscintigraphy for functional confirmation and regional guidance and to inform the route and approximate time window for intraoperative fluorescence mapping, and (4) when high-output ascites persists and focal localization remains elusive, consider intraoperative ICG fluorescence lymphography (with or without additional lymphatic imaging) to achieve focal confirmation and guide treatment. Because tracer and fluorescence transit times may vary with injection technique and patient factors, the time course should be interpreted as an approximate guide rather than a universal rule. Incorporating fluorescence lymphography may accelerate definitive control in selected pediatric patients by enabling direct visualization of a focal leak and immediate intraoperative feedback. In refractory pediatric chylous ascites, planar lymphoscintigraphy may suggest abnormal lymphatic flow; however, it is insufficient for precise localization. Intraoperative ICG fluorescence lymphography can provide real-time functional mapping to identify focal leaks and assess immediate treatment response, serving as a useful adjunct within a multimodality imaging approach. This case illustrates a sequential imaging approach in infants: lymphoscintigraphy for functional/regional guidance followed by intraoperative pedal ICG for dynamic focal localization while limiting additional radiation exposure. Authors’ contributions TY drafted the manuscript. RS, RT, and SI were responsible for perioperative patient management. RS and SI supervised manuscript writing. All authors reviewed and approved the final version of the manuscript. Availability of data and materials The authors declare that all data in this manuscript are available within the article. Ethics approval and consent to participate The off-label use of indocyanine green was approved by the Institutional Ethics Review Committee, and written informed consent was obtained from the patient’s guardian. Patient consent Written informed consent was obtained from the patient’s legal guardian for publication of this case report and accompanying images.